Projects per year
Personal profile
Education
- 2022.07.03-2022.07.16 University of Oxford
- 2007 Ph.D., National Taiwan University Pathology
- 1998 MS, National Taiwan University Pathology
- 1996 BS.. China Medical University Medical Technology
Experience
- 2021- Associate Professor, Ph.D. Program in Medical Biotechnology, Taipei Medical University
- 2021- Associate Professor, School of Medical Laboratory Science and Biotechnology Assistant Professor, Taipei Medical University
- 2015-2021 Assistant Professor, Ph.D. Program in Medical Biotechnology, Taipei Medical University
- 2013-2021 Assistant Professor, School of Medical Laboratory Science and Biotechnology Assistant Professor, Taipei Medical University
- 2009 Seattle Childrens Research Institute fellow Ph.D
- 2007 Department of medical Laboratory Science and Biotechnology fellow Ph.D.
Awards
- 2011 53rd ASH abstract achievement awards- American Society of Hematology
- 2013 55rd ASH abstract achievement awards- American Society of Hematology
- 2013-2015 NSC University outstanding investigator recruitment award
- 2016 Excellent research paper award-Teachers and students joint academic research symposium (TMU)
- 2020 AAI Early Career Faculty Travel Grant - American Association of Immunologists (AAI)
Research Interests
- Immunotherapy
- Oncology
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 12 Finished
-
CDK Inhibitor-Mediated PD-L1 Upregulation Enhances OC Responsiveness to CAR-Based Regimen Targeting
Liu, C.-L. (PI)
7/1/23 → 2/29/24
Project: A - Government Institution › b - National Science and Technology Council
-
PAR1嵌合抗體T細胞及T調節細胞在臨床治療上的多功能應用
Liu, C.-L. (PI)
8/1/22 → 7/31/23
Project: B - Project of TMU › i - Other (Funded by TMU)
-
Targeting Ovarian Cancers with Chimeric Antigens Receptor (Cars) T-Cells Mediated Immunotherapy
Liu, C.-L. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
Targeting Ovarian Cancers with Chimeric Antigens Receptor (Cars) T-Cells Mediated Immunotherapy
Liu, C.-L. (PI)
8/1/20 → 7/1/21
Project: A - Government Institution › b - National Science and Technology Council
-
Targeting Ovarian Cancers with Chimeric Antigens Receptor (Cars) T-Cells Mediated Immunotherapy(1/3)
Liu, C.-L. (PI)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
Discovery of differentially expressed proteins for CAR-T therapy of ovarian cancers with a bioinformatics analysis
Anurogo, D., Liu, C. L., Chang, Y. C., Chang, Y. H. & Qiu, J. T., Jul 18 2024, In: Aging. 16, 14, p. 11409-11433 25 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Enhancement of Tumorigenicity, Spheroid Niche, and Drug Resistance of Pancreatic Cancer Cells in Three-Dimensional Culture System
Hung, H. C., Mao, T. L., Fan, M. H., Huang, G. Z., Minhalina, A. P., Chen, C. L. & Liu, C. L., 2024, In: Journal of Cancer. 15, 8, p. 2292-2305 14 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Effect of chimeric antigen receptor T cells against protease-activated receptor 1 for treating pancreatic cancer
Hung, H. C., Fan, M. H., Wang, D., Miao, C. H., Su, P. & Liu, C. L., Dec 2023, In: BMC Medicine. 21, 1, 338.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus) -
LncRNA MALAT1 facilitates ovarian cancer progression through promoting chemoresistance and invasiveness in the tumor microenvironment
Mao, T. L., Fan, M. H., Dlamini, N. & Liu, C. L., Oct 2021, In: International journal of molecular sciences. 22, 19, 10201.Research output: Contribution to journal › Article › peer-review
Open Access31 Citations (Scopus) -
The molecular landscape influencing prognoses of epithelial ovarian cancer
Liu, C. L., Yuan, R. H. & Mao, T. L., Jul 2021, In: Biomolecules. 11, 7, 998.Research output: Contribution to journal › Review article › peer-review
Open Access5 Citations (Scopus)